Human Growth Hormone Induced Cholestatic Hepatitis in a Growth Hormone Deficient Patient with Short Stature

Author(s): Mozhghan Zahmatkeshan, Zohre Karamizadeh, Bita Geramizadeh, Ahad Eshraghian

Journal Name: Current Drug Safety

Volume 9 , Issue 1 , 2014

Become EABM
Become Reviewer
Call for Editor


Case Description: We report a patient with growth hormone deficiency that developed cholestatic hepatitis during treatment with recombinant human growth hormone (HGH). The patient developed jaundice and pruritus during treatment with growth hormone. She did not use any other medications. Her jaundice and pruritus were disappeared and liver enzyme disturbances were normalized after HGH discontinuation.

Conclusion: Clinician should be aware of this potential adverse drug reaction and frequent checking of liver enzymes is recommended in patients treating with HGH.

Keywords: Cholestatic hepatitis, human growth hormone, growth hormone deficiency.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Published on: 24 February, 2014
Page: [63 - 64]
Pages: 2
DOI: 10.2174/1574886308666131217115453

Article Metrics

PDF: 50